SIGA Technologies(us:SIGA)

    5.92

    +0.17%

    Updated on 2024-12-23

    Open:5.92
    Close:5.92
    High:6.01
    Low:5.74
    Pre Close:5.91
    Volume:224695.00
    Amount:1.33M
    Turnover:0.31%
    Shares:71.40M
    MarketCap:422.72M
    DateTotalTotal SharesTotal RatioNewIncreasedDecreased
    2024-06-301683368118747.23%295361
    2024-03-311533354774447.17%264259
    2023-12-311383408638447.95%124949
    2023-09-301483437386148.35%204462
    2023-06-301543314545846.63%164475
    2023-03-311733161924344.20%194881
    2022-12-311833094776842.58%315074
    2022-09-301792879709639.44%405170
    dateorgNametotalratiochangeShareschangeRatio
    2024-03-31Blackrock Inc.34553094.86%-58581-1.67%
    2024-03-31First Wilshire Securities Management Inc26542553.73%29214812.37%
    2024-03-31Vanguard Group Inc22836123.21%415151.85%
    2024-03-31Van Lanschot Kempen Investment Management N.V.22035083.10%-70851-3.12%
    2024-03-31Altravue Capital, Llc20431962.87%0
    2024-03-31Dimensional Fund Advisors Lp16879052.37%-10249-0.60%
    2024-03-31Federated Hermes, Inc.15765852.22%-1643263-51.03%
    2024-03-31Goldman Sachs Group Inc15280102.15%-119445-7.25%
    2024-03-31State Street Corp11044051.55%505454.80%
    2024-03-31Hotchkis & Wiley Capital Management Llc10911601.53%662006.46%

    About

    SIGA Technologies, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. The firm develops therapeutic solutions for lethal pathogens including smallpox, Ebola, dengue, Lassa fever, and other dangerous viruses. It offers an orally administered antiviral drug that targets orthopoxviruses under the TPOXX brand. The company was founded by Steven Oliveira on December 28, 1995 and is headquartered in New York, NY.
    Address:31 East 62nd Street

    Market Movers